COPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg daily

dc.contributor[Ziemssen, T.] Klinikum Carl Gustav Carus, Dresden, Germany; [Bajenaru, O.] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Carra, A.] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina; [de Klippel, N.] Virga Jessaziekenhuis, Hasselt, Belgium; [de Sa, J.] Hosp Santa Maria, Lisbon, Portugal; [Edland, A.] Cent Hosp Buskerud, Drammen, Norway; [Frederiksen, J.] Univ Copenhagen, Glostrup, Denmark; [Heinzlef, O.] Tenon Hosp, Paris, France; [Karageorgiou, K.] G Gennimatas Gen Hosp Athens, Athens, Greece; [Landtblom, A. M.] Linkoping Univ, Linkoping, Sweden; [Macias Islas, M.] Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Tubridy, N.] Univ Coll Dublin, Dublin 2, Ireland; [Gilgun-Sherki, Y.] Teva Pharmaceut Ind, Petah Tiqwa, Israel
dc.creatorZiemssen, T
dc.creatorBajenaru, O
dc.creatorCarra, A
dc.creatorde Klippel, N
dc.creatorde Sa, J
dc.creatorEdland, A
dc.creatorFrederiksen, J
dc.creatorHeinzlef, O
dc.creatorKarageorgiou, K
dc.creatorLandtblom, AM
dc.creatorIslas, MM
dc.creatorTubridy, N
dc.creatorGilgun-Sherki, Y
dc.date.accessioned2015-09-15T19:24:35Z
dc.date.accessioned2023-07-03T21:33:48Z
dc.date.available2015-09-15T19:24:35Z
dc.date.available2023-07-03T21:33:48Z
dc.date.created2015-09-15T19:24:35Z
dc.date.issued2013
dc.identifier1352-4585
dc.identifierhttp://hdl.handle.net/20.500.12104/46256
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7241751
dc.languageEnglish
dc.publisherSAGE PUBLICATIONS LTD
dc.relationWOS
dc.relationMULTIPLE SCLEROSIS JOURNAL
dc.relation19
dc.relation11
dc.relation444
dc.relation445
dc.titleCOPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg daily
dc.typeMeeting Abstract


Este ítem pertenece a la siguiente institución